Opus Genetics
IRD
16 hedge funds and large institutions have $422K invested in Opus Genetics in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.
0.17% more ownership
Funds ownership: 1.12% → 1.29% (+0.17%)
0% more funds holding
Funds holding: 16 → 16 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
55% less capital invested
Capital invested by funds: $930K → $422K (-$508K)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$79.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$19K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$2.38K |
| 4 |
NFG
Next Financial Group
Houston,
Texas
|
+$584 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$4K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.88K |
| 3 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$654 |
| 4 |
Morgan Stanley
New York
|
-$376 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$362 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $224K | +$79.6K | +5,721 | +27% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $113K | -$3.88K | -279 | -2% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $54K | – | – | – |
|
4
BlackRock
New York
| $18K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $12K | +$19K | +1,367 | +3,255% |
|
|
6
Victory Capital Management
San Antonio,
Texas
| $1K | +$2.38K | +171 | New |
|
|
APA
7
American Portfolios Advisors
Holbrook,
New York
| $16 | – | – | – |
|
|
8
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$4K | -177 | Closed |
|
|
LTFS
9
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$654 | -47 | -71% |
|
|
10
Morgan Stanley
New York
| – | -$376 | -27 | -41% |
|
|
11
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$362 | -26 | -84% |
|
12
Bank of America
Charlotte,
North Carolina
| – | -$181 | -13 | -24% |
|
|
NFG
13
Next Financial Group
Houston,
Texas
| – | +$584 | +42 | New |
|
IRD Hedge Fund Activity: Q3 2019 in Review
16 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q3 2019, worth a combined $422K — down 55% from $930K a quarter earlier.
Fund positioning in IRD was balanced in Q3 2019: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 5 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $79.6K. The largest seller was Bank of Montreal, exiting entirely with an estimated $4K sold.
- 16 institutional investors held Opus Genetics (IRD) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $422K of Opus Genetics stock for Q3 2019, down 55% quarter-over-quarter.
- 2 funds opened new Opus Genetics positions in Q3 2019 and 2 closed out, a net change of 0 holders.
- The largest Opus Genetics buyer in Q3 2019 was Renaissance Technologies, an estimated $79.6K added.
- The largest Opus Genetics seller in Q3 2019 was Bank of Montreal, an estimated $4K sold.
Based on aggregated 13F filings for Q3 2019.